Concepedia

B. Yа. Alekseev

BY

129

Publications

22.3K

Citations

45

H-Index

2007

Active since

Affiliations

P.A. Hertzen Moscow Oncology Research Institute(Current)

Ministry of Health of the Russian Federation

Engelhardt Institute of Molecular Biology

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Tübingen

B. Yа. Alekseev is an author at P.A. Hertzen Moscow Oncology Research Institute specializing in medicine, oncology, and urology.

ORCID

Top concepts

Publications per year

2007–2025

129

Publications

129

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · New England Journal of Medicine · 2019 · 3.3K citations · Full text

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Robert J. Motzer, Konstantin Penkov, John B.A.G. Haanen et al. · New England Journal of Medicine · 2019 · 2.5K citations · Full text

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Karim Fizazi, NamPhuong Tran, Luis Fein et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2019 · 1.1K citations · Full text

Rows per page

1–5 of 129